A detailed history of Rothschild Investment LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 120 shares of NEO stock, worth $1,892. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Previous 30 300.0%
Holding current value
$1,892
Previous $416,000 325.48%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$13.4 - $17.73 $1,206 - $1,595
90 Added 300.0%
120 $1.77 Million
Q2 2024

Jul 30, 2024

BUY
$13.01 - $15.77 $390 - $473
30 New
30 $416,000
Q1 2024

Jul 31, 2024

SELL
$14.06 - $16.79 $281 - $335
-20 Reduced 66.67%
10 $157,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.98B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.